Literature DB >> 2404627

Angiotensin converting enzyme inhibition and its impact on cardiovascular disease.

H Gavras1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2404627     DOI: 10.1161/01.cir.81.1.381

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

1.  The renin-angiotensin system antagonism in the treatment of hypertension.

Authors:  J D Bisognano; R J Cody
Journal:  Curr Hypertens Rep       Date:  1999-08       Impact factor: 5.369

2.  Comparison of the effects of ACE inhibition with those of angiotensin II receptor antagonism on systolic and diastolic myocardial stunning in isolated rabbit heart.

Authors:  C Morales; M Rodríguez; O Scapín; R J Gelpi
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

Review 3.  Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity.

Authors:  Tsuneharu Baba; Takashi Ishizaki
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 4.  Angiotensin II--nitric oxide interactions in the control of sympathetic outflow in heart failure.

Authors:  I H Zucker; J L Liu
Journal:  Heart Fail Rev       Date:  2000-03       Impact factor: 4.214

Review 5.  Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure.

Authors:  Irving H Zucker; Harold D Schultz; Kaushik P Patel; Wei Wang; Lie Gao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

6.  Synthetic peptides as structural maquettes of Angiotensin-I converting enzyme catalytic sites.

Authors:  Zinovia Spyranti; Athanassios S Galanis; George Pairas; Georgios A Spyroulias; Evy Manessi-Zoupa; Paul Cordopatis
Journal:  Bioinorg Chem Appl       Date:  2010-06-09       Impact factor: 7.778

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.